World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
271 ECO Animal Health Group plc $96.3 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
272 Zomedica Corp. $95.3 M

(May 1, 2025)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
273 MPH HEALTH CARE AG KONV $95.3 M

(July 1, 2025)

 Germany German Healthcare German Drug Manufacturers—Specialty & Generic
274 Kyongbo Pharmaceutical Co. Ltd $94.5 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
275 Maywufa Company Ltd $92.5 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
276 Vistin Pharma ASA $91.5 M

(July 1, 2024)

 Norway Norway Healthcare Norway Drug Manufacturers—Specialty & Generic
277 InterCure Ltd $89.6 M

(July 1, 2025)

 Israel Israeli Healthcare Israeli Drug Manufacturers—Specialty & Generic
278 PT Merck Tbk $88.3 M Indonesia Indonesian Healthcare Indonesian Drug Manufacturers—Specialty & Generic
279 Harborside, Inc. $86.2 M

(Sept. 1, 2022)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
280 Johnson Chemical Pharmaceutical Works Co. Ltd $86.1 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
281 PhytoHealth Corp $85.6 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
282 Vita Life Sciences Limited $81.9 M

(July 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
283 Oasmia Pharmaceutical AB $76.7 M

(June 1, 2022)

 Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
284 Golden Biotechnology Corp $75.1 M

(July 1, 2025)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
285 Medexus Pharmaceuticals, Inc. $73.5 M

(July 1, 2025)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
286 Green Organic Dutchman Holdings Ltd. $71.7 M

(Sept. 1, 2021)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
287 BioHarvest Sciences, Inc. $71.3 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
288 Fusen Pharmaceutical Company Ltd $71.2 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
289 Endo International plc $68.8 M

(Oct. 1, 2022)

 Ireland Irish Healthcare Irish Drug Manufacturers—Specialty & Generic
290 FUREN Group Pharmaceutical Co. Ltd $66.6 M

(June 1, 2023)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
291 Orexo AB $66.0 M

(July 1, 2024)

 Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
292 OptiNose, Inc. $65.9 M

(Jan. 1, 2025)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
293 LIWANLI Innovation Co. Ltd $65.4 M

(July 1, 2025)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
294 Zhongzhi Pharmaceutical Holdings Ltd $64.0 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
295 GeneFerm Biotechnology Co. Ltd $63.7 M

(July 1, 2025)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
296 Allied Biotech Corp $63.3 M

(July 1, 2025)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
297 TSH Biopharm Corp Ltd $63.2 M

(July 1, 2025)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
298 Wakamoto Pharmaceutical Co.,Ltd. $63.1 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
299 Jushi Holdings, Inc. $62.9 M

(July 1, 2025)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
300 InnoPharmax, Inc. $61.9 M

(July 1, 2025)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

271. ECO Animal Health Group plc

Company Profile: ECO Animal Health Group plc
Market Cap (USD): $96.3 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

272. Zomedica Corp.

Company Profile: Zomedica Corp.
Market Cap (USD): $95.3 M (May 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

273. MPH HEALTH CARE AG KONV

Company Profile: MPH HEALTH CARE AG KONV
Market Cap (USD): $95.3 M (July 1, 2025)
Country: Germany
Sector: German Healthcare
Industry: German Drug Manufacturers—Specialty & Generic

274. Kyongbo Pharmaceutical Co. Ltd

Company Profile: Kyongbo Pharmaceutical Co. Ltd
Market Cap (USD): $94.5 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

275. Maywufa Company Ltd

Company Profile: Maywufa Company Ltd
Market Cap (USD): $92.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

276. Vistin Pharma ASA

Company Profile: Vistin Pharma ASA
Market Cap (USD): $91.5 M (July 1, 2024)
Country: Norway
Sector: Norway Healthcare
Industry: Norway Drug Manufacturers—Specialty & Generic

277. InterCure Ltd

Company Profile: InterCure Ltd
Market Cap (USD): $89.6 M (July 1, 2025)
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Drug Manufacturers—Specialty & Generic

278. PT Merck Tbk

Company Profile: PT Merck Tbk
Market Cap (USD): $88.3 M
Country: Indonesia
Sector: Indonesian Healthcare
Industry: Indonesian Drug Manufacturers—Specialty & Generic

279. Harborside, Inc.

Company Profile: Harborside, Inc.
Market Cap (USD): $86.2 M (Sept. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

280. Johnson Chemical Pharmaceutical Works Co. Ltd

Company Profile: Johnson Chemical Pharmaceutical Works Co. Ltd
Market Cap (USD): $86.1 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

281. PhytoHealth Corp

Company Profile: PhytoHealth Corp
Market Cap (USD): $85.6 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

282. Vita Life Sciences Limited

Company Profile: Vita Life Sciences Limited
Market Cap (USD): $81.9 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

283. Oasmia Pharmaceutical AB

Company Profile: Oasmia Pharmaceutical AB
Market Cap (USD): $76.7 M (June 1, 2022)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

284. Golden Biotechnology Corp

Company Profile: Golden Biotechnology Corp
Market Cap (USD): $75.1 M (July 1, 2025)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

285. Medexus Pharmaceuticals, Inc.

Company Profile: Medexus Pharmaceuticals, Inc.
Market Cap (USD): $73.5 M (July 1, 2025)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

286. Green Organic Dutchman Holdings Ltd.

Company Profile: Green Organic Dutchman Holdings Ltd.
Market Cap (USD): $71.7 M (Sept. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

287. BioHarvest Sciences, Inc.

Company Profile: BioHarvest Sciences, Inc.
Market Cap (USD): $71.3 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

288. Fusen Pharmaceutical Company Ltd

Company Profile: Fusen Pharmaceutical Company Ltd
Market Cap (USD): $71.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

289. Endo International plc

Company Profile: Endo International plc
Market Cap (USD): $68.8 M (Oct. 1, 2022)
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Drug Manufacturers—Specialty & Generic

290. FUREN Group Pharmaceutical Co. Ltd

Company Profile: FUREN Group Pharmaceutical Co. Ltd
Market Cap (USD): $66.6 M (June 1, 2023)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

291. Orexo AB

Company Profile: Orexo AB
Market Cap (USD): $66.0 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

292. OptiNose, Inc.

Company Profile: OptiNose, Inc.
Market Cap (USD): $65.9 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

293. LIWANLI Innovation Co. Ltd

Company Profile: LIWANLI Innovation Co. Ltd
Market Cap (USD): $65.4 M (July 1, 2025)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

294. Zhongzhi Pharmaceutical Holdings Ltd

Company Profile: Zhongzhi Pharmaceutical Holdings Ltd
Market Cap (USD): $64.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

295. GeneFerm Biotechnology Co. Ltd

Company Profile: GeneFerm Biotechnology Co. Ltd
Market Cap (USD): $63.7 M (July 1, 2025)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

296. Allied Biotech Corp

Company Profile: Allied Biotech Corp
Market Cap (USD): $63.3 M (July 1, 2025)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

297. TSH Biopharm Corp Ltd

Company Profile: TSH Biopharm Corp Ltd
Market Cap (USD): $63.2 M (July 1, 2025)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

298. Wakamoto Pharmaceutical Co.,Ltd.

Company Profile: Wakamoto Pharmaceutical Co.,Ltd.
Market Cap (USD): $63.1 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

299. Jushi Holdings, Inc.

Company Profile: Jushi Holdings, Inc.
Market Cap (USD): $62.9 M (July 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

300. InnoPharmax, Inc.

Company Profile: InnoPharmax, Inc.
Market Cap (USD): $61.9 M (July 1, 2025)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

Stay in touch